The Biomarker Core provides a unique resource to the TTURC investigators. This Core will provide not only biomarker measurements, but also expertise in the interpretation of these data and their application in the design of further research approaches toward reduction of tobacco associated diseases. The work of this Core is highly integrated into all projects of the TTURC. The expertise of this Core in tobacco carcinogenesis, nicotine biochemistry, and carcinogen metabolism adds an important dimension to this TTURC. The work of the Biomarker Core will center around two main broad themes: 1) measurement of nicotine metabolites and biomarkers of carcinogen uptake to assess the relationship of tobacco exposure at various levels to uptake of nicotine and carcinogens and 2) the relationship of nicotine metabolism, as mediated by cytochrome P450 2A6, to susceptibility to cigarette use. The following alkaloids, metabolites, and adducts will be quantified in this work: nicotine metabolites including nicotine-glucuronide, cotinine, cotinine-glucuronide, trans~3?~ hydroxycotinine, and trans-3'-hydroxycotinine-glucuronide; 7- hydroxycoumarin as a measure of cytochrome P450 2A6 activity; 4- (methylnitrosamino)-l-(3-pyridyl)-l-butanol (NNAL) and its glucuronide (NNAL-Gluc) as measures of uptake of the tobacco-specific lung carcinogen 4-(methylnitrosarnino)-I-(3-pyridyl)-l-butanone (NNK); I- hydroxypyrene as a measure of uptake of carcinogenic polycyclic aromatic hydrocarbons; 4-aminobiphenyl-hemoglobin adducts as indicators of the uptake and metabolic activation of the human bladder carcinogen 4- aminobiphenyl; F2-isoprostanes as indicators of oxidative damage associated with cigarette smoking; and metabolites of NNK as influenced by nicotine administration. Collectively, these biomarkers will substantially enhance our understanding of the biochemical and mechanistic aspects of the tobacco exposure reduction strategies being explored in this TTURC.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
1P50DA013333-01
Application #
6259743
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (O2))
Project Start
1999-09-30
Project End
2004-09-29
Budget Start
Budget End
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Burns, Rachel J; Rothman, Alexander J; Fu, Steven S et al. (2016) Longitudinal Care Improves Cessation in Smokers Who Do Not Initially Respond to Treatment by Increasing Cessation Self-Efficacy, Satisfaction, and Readiness to Quit: A Mediated Moderation Analysis. Ann Behav Med 50:58-69
Konorev, Dmitri; Koopmeiners, Joseph S; Tang, Yijin et al. (2015) Measurement of the Heterocyclic Amines 2-Amino-9H-pyrido[2,3-b]indole and 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in Urine: Effects of Cigarette Smoking. Chem Res Toxicol 28:2390-9
Hatsukami, Dorothy K; Donny, Eric C; Koopmeiners, Joseph S et al. (2015) Compensatory smoking from gradual and immediate reduction in cigarette nicotine content. Cancer Epidemiol Biomarkers Prev 24:472-6
Burns, Rachel J; Rothman, Alexander J; Fu, Steven S et al. (2014) The relation between social support and smoking cessation: revisiting an established measure to improve prediction. Ann Behav Med 47:369-75
Oliver, Andrew J; Jensen, Joni A; Vogel, Rachel I et al. (2013) Flavored and nonflavored smokeless tobacco products: rate, pattern of use, and effects. Nicotine Tob Res 15:88-92
Knezevich, Aleksandar; Muzic, John; Hatsukami, Dorothy K et al. (2013) Nornicotine nitrosation in saliva and its relation to endogenous synthesis of N'-nitrosonornicotine in humans. Nicotine Tob Res 15:591-5
Anderson, Kristin E; Mongin, Steven J; Sinha, Rashmi et al. (2012) Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort. Mol Carcinog 51:128-37
Stepanov, Irina; Knezevich, Aleksandar; Zhang, Liqin et al. (2012) Carcinogenic tobacco-specific N-nitrosamines in US cigarettes: three decades of remarkable neglect by the tobacco industry. Tob Control 21:44-8
Hecht, Stephen S; Stepanov, Irina; Hatsukami, Dorothy K (2011) Major tobacco companies have technology to reduce carcinogen levels but do not apply it to popular smokeless tobacco products. Tob Control 20:443
Harris, Andrew C; Pentel, Paul R; Burroughs, Danielle et al. (2011) A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats. Psychopharmacology (Berl) 217:153-66

Showing the most recent 10 out of 132 publications